World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
21767
World Ranking
1692
National Ranking
833

Medicine

D-Index
79
Citations
22537
World Ranking
17577
National Ranking
8788

Michael K. Racke publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael K. Racke sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 260 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael K. Racke D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael K. Racke sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael K. Racke is affiliated with Quest Diagnostics in the United States and has contributed extensively to the field of medicine, with a particular focus on neurology. Their scholarly work encompasses 66 publications primarily within medicine, covering multiple subfields including neurology, immunology, infectious diseases, pathology and forensic medicine, and physiology.

Their research topics span several areas, including:

  • Multiple Sclerosis Research Studies
  • Alzheimer's disease research and treatments
  • SARS-CoV-2 and COVID-19 Research
  • Peripheral Neuropathies and Disorders
  • Dementia and Cognitive Impairment Research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers

Frequent publication venues for their work include:

  • Annals of Clinical and Translational Neurology
  • Journal of Neuroimmunology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neurology
  • Alzheimer s & Dementia

They have collaborated often with several co-authors, including:

  • Jennifer Graves
  • John A. Kessler
  • Leon G. Epstein
  • Ahmet Höke
  • Johns Hopkins

Among their recent published papers are:

  • "Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial" (2023) in The Lancet Neurology
  • "Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients" (2020) in Multiple Sclerosis Journal
  • "Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinical Vignettes" (2022) in Frontiers in Neurology
  • "A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg Balance" (2021) in JCI Insight
  • "Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment" (2024) in Frontiers in Neurology

Best Publications

  • Multiple Sclerosis — The Plaque and Its Pathogenesis

    Elliot M. Frohman;Michael K. Racke;Cedric S. Raine

  • Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

    M.K. Racke;A. Bonomo;D.E. Scott;B. Cannella

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

  • T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis

    Jeffrey M. Critchfield;Michael K. Racke;Juan Carlos Zúñiga-Pflücker;Barbara Cannella

  • Immune surveillance in multiple sclerosis patients treated with natalizumab

    Olaf Stüve;Olaf Stüve;Christina M Marra;Keith R Jerome;Keith R Jerome;Keith R Jerome;Linda Cook;Linda Cook;Linda Cook

  • Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

    M K Racke;S Dhib-Jalbut;B Cannella;P S Albert

  • Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells

    Kamran Ghoreschi;Jürgen Brück;Christina Kellerer;Caishu Deng

  • Peroxisome Proliferator-Activated Receptor-γ Agonist 15-Deoxy-Δ12,1412,14-Prostaglandin J2 Ameliorates Experimental Autoimmune Encephalomyelitis

    Asim Diab;Caishu Deng;Jeff D. Smith;Rehana Z. Hussain

  • T-bet is essential for encephalitogenicity of both Th1 and Th17 cells.

    Yuhong Yang;Jeffrey Weiner;Yue Liu;Alan J. Smith

  • Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.

    M. K. Racke;D. Burnett;Seong-Hee Pak;P. S. Albert

  • Factors that influence adherence with disease-modifying therapy in MS.

    Katherine Treadaway;Gary Cutter;Amber Salter;Sharon Lynch

  • High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay

    Michael P. Crawford;Shirley X. Yan;Sterling B. Ortega;Riyaz S. Mehta

  • Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

    Amy E. Lovett-Racke;John L. Trotter;Joanne Lauber;Peter J. Perrin

  • T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity

    Anne R. Gocke;Petra D. Cravens;Li Hong Ben;Rehana Z. Hussain

  • Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis.

    Olaf Stüve;Christina M. Marra;Amit Bar-Or;Masaaki Niino

  • IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

    Martin Röcken;Michael Racke;Ethan M. Shevach

  • CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis.

    P J Perrin;J H Maldonado;T A Davis;C H June

  • Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

    R. Zivadinov;A. T. Reder;M. Filippi;A. Minagar

  • Effect of Rituximab on the Peripheral Blood and Cerebrospinal Fluid B Cells in Patients With Primary Progressive Multiple Sclerosis

    Nancy L. Monson;Petra D. Cravens;Elliot M. Frohman;Kathleen Hawker

  • The utility of MRI in suspected MS: report of the Therapeutics and technology assessment Subcommittee of the American Academy of Neurology

    EM Frohman;DS Goodin;PA Calabresi;JR Corboy

  • Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis

    Mark S. Freedman;Edward J. Thompson;Florian Deisenhammer;Gavin Giovannoni

Frequent Co-Authors

Amy E. Lovett-Racke
Amy E. Lovett-Racke The Ohio State University Wexner Medical Center
Elliot M. Frohman
Elliot M. Frohman The University of Texas at Austin
Olaf Stüve
Olaf Stüve The University of Texas Southwestern Medical Center
Anne H. Cross
Anne H. Cross Washington University in St. Louis
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
Dale E. McFarlin
Dale E. McFarlin National Institutes of Health
Carl H. June
Carl H. June University of Pennsylvania
Richard A. Nash
Richard A. Nash Fred Hutchinson Cancer Research Center
Henry F. McFarland
Henry F. McFarland National Institutes of Health
Douglas L. Arnold
Douglas L. Arnold Montreal Neurological Institute and Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career options. Many students pursue advanced nursing programs, such as psychiatric nurse practitioner tracks. Finding the best pmhnp programs online ensures strong clinical placement opportunities, which are critical for gaining hands-on experience.

Cost is another important factor when selecting a program. The cheapest psychiatric nurse practitioner programs provide affordable pathways without compromising quality, making advanced education accessible to a wider range of students.

Career outlook is equally essential. Understanding how much do dnp nurses make can help guide financial and professional expectations. Salaries often vary by location, specialty, and certification, influencing long-term career decisions.

For those already in nursing, transitioning specializations is possible through certifications like acute care nurse practitioner certification. This step can broaden clinical skills and open doors to acute care settings, which may complement immunology-related roles.

Best Scientists Citing Michael K. Racke

Trending Scientists

Recently Published Articles